Abbott Laboratories (ABT)
114.72
+0.41
(+0.36%)
USD |
NYSE |
Dec 24, 13:00
114.88
+0.16
(+0.14%)
After-Hours: 13:59
Abbott Laboratories Cash from Investing (Quarterly): -594.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Haemonetics Corp | -23.37M |
| Globus Medical Inc | -14.97M |
| Becton Dickinson & Co | -3.937B |
| Masimo Corp | -13.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.705B |
| Cash from Financing (Quarterly) | -1.576B |
| Free Cash Flow | 6.486B |
| Free Cash Flow Per Share (Quarterly) | 1.230 |
| Free Cash Flow to Equity (Quarterly) | 1.924B |
| Free Cash Flow to Firm (Quarterly) | 2.192B |
| Free Cash Flow Yield | 3.23% |